Jim Simons
CNTX icon

Jim Simons’s Context Therapeutics CNTX Stock Holding History

Jim Simons’s Portfolio CNTX Stock Details CNTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$577K Buy
1,041,399
+858,400
+469% +$1.74M ﹤0.01% 2549
2026
Q1 		$479K Sell
182,999
-325,330
-64% -$760K ﹤0.01% 2617
2025
Q4 		$747K Buy
508,329
+188,202
+59% +$220K ﹤0.01% 2406
2025
Q3 		$310K Sell
320,127
-43,803
-12% -$35.5K ﹤0.01% 2980
2025
Q2 		$238K Sell
363,930
-61,570
-14% -$44.3K ﹤0.01% 3115
2025
Q1 		$260K Buy
425,500
+87,065
+26% +$75.8K ﹤0.01% 2979
2024
Q4 		$355K Buy
338,435
+272,435
+413% +$471K ﹤0.01% 2987
2024
Q3 		$129K Buy
66,000
+800
+1% +$1.77K ﹤0.01% 3213
2024
Q2 		$131K Buy
65,200
+25,300
+63% +$43.6K ﹤0.01% 3135
2024
Q1 		$55K Buy
39,900
+7,700
+24% +$8.66K ﹤0.01% 3470
2023
Q4 		$36K Buy
32,200
+2,100
+7% +$2.26K ﹤0.01% 3505
2023
Q3 		$45K Buy
30,100
+1,800
+6% +$2.04K ﹤0.01% 3419
2023
Q2 		$45K Buy
28,300
+9,100
+47% +$7.74K ﹤0.01% 3635
2023
Q1 		$11K Sell
19,200
-86,100
-82% -$65.2K ﹤0.01% 3880
2022
Q4 		$69K Sell
105,300
-25,288
-19% -$27.2K ﹤0.01% 3722
2022
Q3 		$145K Buy
+130,588
New +$235K ﹤0.01% 3488
2022
Q2 		– Sell
-20,309
Closed -$44K – 4264
2022
Q1 		$44K Sell
20,309
-44,309
-69% -$93.2K ﹤0.01% 3926
2021
Q4 		$172K Buy
+64,618
New +$322K ﹤0.01% 3564

Other funds holding CNTX

SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
BOCH
Blue Owl Capital Holdings New York $665M AUM 95.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Jim Simons's CNTX Position: Q2 2026 in Review

Jim Simons increased its Context Therapeutics (CNTX) stake by 469% in Q2 2026, buying an estimated $1.74M and bringing the position to 1,041,399 shares worth $577K. The position accounts for ﹤0.01% of the portfolio, ranked #2549.

Jim Simons first reported a position in CNTX in Q4 2021 and has held it in 18 quarters since. The position peaked at $747K in Q4 2025. 43 funds tracked by Wall St. Rank hold CNTX as of Q2 2026.

  • Jim Simons held 1,041,399 shares of Context Therapeutics worth $577K as of Q2 2026.
  • Jim Simons bought 858,400 Context Therapeutics shares in Q2 2026, an estimated $1.74M.
  • Context Therapeutics made up ﹤0.01% of Jim Simons's portfolio in Q2 2026, its #2549 holding.
  • Jim Simons first reported a position in Context Therapeutics in Q4 2021 and has held it in 18 quarters since.
  • Jim Simons's Context Therapeutics position peaked at $747K in Q4 2025.
  • 43 funds tracked by Wall St. Rank held Context Therapeutics as of Q2 2026.

Based on Renaissance Technologies's 13F filing for Q2 2026, filed 13 Aug 2026.